Fresenius SE FRE0.00%increase; green up pointing triangle raised its full-year guidance after a strong third quarter driven by Kabi and good organic growth at Helios. The German healthcare company ...

Lindsey (Fresenius Kabi USA): As these themes may be difficult topics for some organizations, I think Fresenius Kabi has cultivated a strong culture that values everyone’s contributions. The ...

Fresenius Kabi is unveiling a portfolio of generic contrast media agents in the United States, starting immediately with the launch of iodixanol injection, which is the generic of GE Healthcare's ...

Fresenius Kabi is offering Rocuronium Bromide injection with advanced RFID-enabled labels. The product is the generic of Zemuron. Rocuronium Bromide injection is part of Fresenius Kabi's +RFID ...

FRANKFURT, May 25 (Reuters) - German healthcare group Fresenius SE FREG.DE lifted its earnings target for generic hospital drugs unit Kabi, citing demand for blood plasma products and clinical ...

LAKE ZURICH, Ill., November 14, 2024--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today it received a Novaplus Program Excellence Award from Vizient, Inc., the ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies ...

Injectable medicine and biosimilar maker Fresenius Kabi said today Arunesh Verma is the new president of Lake Zurich-based Fresenius Kabi USA. He succeeds John Ducker, who is retiring after 35 ...

LAKE ZURICH - Fresenius Kabi said Monday it has launched Ganirelix Acetate Injection, a generic fertility drug, as part of the company's expansion in women's health. Ganirelix is prescribed to ...

Fresenius Kabi and Formycon have won US Food and Drug Administration (FDA) approval for Otulfi (ustekinumab-aauz), a biosimilar that references Johnson & Johnson’s (J&J) blockbuster inflammatory ...

Fresenius Kabi's tocilizumab biosimilar Tyenne ® is the first and only tocilizumab biosimilar to be launched in Canada and is now commercially available for both subcutaneous and intravenous ...